Evidence map›Paper›PMID 41503005›Full record

ArticleImaging neuroscience (Cambridge, Mass.)2026

TissUnet: Improved extracranial tissue and cranium segmentation for children through adulthood.

Markiian Mandzak, Elvira Yang, Anna Zapaishchykova, Yu-Hui Chen, Lucas Heilbroner, John Zielke, Divyanshu Tak, Reza Mojahed-Yazdi, Francesca Romana Mussa, Zezhong Ye and 10 more

Abstract read
In one paragraph

Article in Imaging neuroscience (Cambridge, Mass.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Markiian MandzakArtificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School, Boston, MA, United States.
Elvira YangArtificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School, Boston, MA, United States.
Anna ZapaishchykovaArtificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School, Boston, MA, United States.ORCID 0000-0001-6860-9160
Yu-Hui ChenDepartment of Data Science, Dana-Farber Cancer Institute, Boston, MA, United States.
Lucas HeilbronerGeorge Washington School of Medicine and Health Sciences, Washington, DC, United States.
John ZielkeArtificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School, Boston, MA, United States.
Divyanshu TakArtificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School, Boston, MA, United States.
Reza Mojahed-YazdiArtificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School, Boston, MA, United States.
Francesca Romana MussaArtificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School, Boston, MA, United States.
Zezhong YeArtificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School, Boston, MA, United States.
Sridhar VajapeyamArtificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School, Boston, MA, United States.
Viviana BenitezBoston Children's Hospital, Boston, MA, United States.
Ralph SalloumDepartment of Pediatric Oncology at Dana-Farber Cancer Institute, Boston, MA, United States.
Susan N ChiBoston Children's Hospital, Boston, MA, United States.
Houman SotoudehUT Southwestern Medical Center, Dallas, TX, United States.
Jakob SeidlitzLifespan Brain Institute, The Children's Hospital of Philadelphia and Penn Medicine, Philadelphia, PA, United States.
Sabine MuellerDepartment of Neurology, Neurosurgery and Pediatrics, University of California, San Francisco, CA, United States.
Hugo J W L AertsArtificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School, Boston, MA, United States.
Tina Y PoussaintDepartment of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
Benjamin H KannArtificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School, Boston, MA, United States.ORCID 0000-0002-4313-2754

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extracranial tissues visible on brain magnetic resonance imaging (MRI) may hold significant value for characterizing health conditions and clinical decision-making, yet they are rarely quantified. Current tools have not been widely validated, particularly in settings of developing brains or underlying pathology. We present TissUnet, a deep learning model that segments skull bone, subcutaneous fat, and muscle from routine three-dimensional T1-weighted MRI, with or without contrast enhancement. The model was trained on 155 paired MRI-computed tomography (CT) scans and validated across nine datasets covering a wide age range and including individuals with brain tumors. In comparison to AI-CT-derived labels from 37 MRI-CT pairs, TissUnet achieved a median Dice coefficient of 0.79 [IQR: 0.77-0.81] in a healthy adult cohort. In a second validation using expert manual annotations, median Dice was 0.83 [IQR: 0.83-0.84] in healthy individuals and 0.81 [IQR: 0.78-0.83] in tumor cases, outperforming a previous state-of-the-art method. Acceptability testing resulted in an 89% acceptance rate after adjudication by a tie-breaker (N = 108 MRIs), and TissUnet demonstrated excellent performance in the blinded comparative review (N = 45 MRIs), including both healthy and tumor cases in pediatric populations. TissUnet enables fast, accurate, and reproducible segmentation of extracranial tissues, supporting large-scale studies on craniofacial morphology, treatment effects, and cardiometabolic risk using standard brain T1w MRI.

Indexed as

artificial intelligencedeep learningMRIpediatric brain tumorwhole-head segmentation

Identifiers

PMID41503005
PMCPMC12770910

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.